SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-029612
Filing Date
2019-08-07
Accepted
2019-08-07 06:03:16
Documents
66
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q surf-10q_20190630.htm 10-Q 2047665
2 EX-31.1 surf-ex311_6.htm EX-31.1 17657
3 EX-31.2 surf-ex312_7.htm EX-31.2 17688
4 EX-32.1 surf-ex321_8.htm EX-32.1 7051
5 EX-32.2 surf-ex322_9.htm EX-32.2 7114
  Complete submission text file 0001564590-19-029612.txt   7262967

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT surf-20190630.xml EX-101.INS 1597308
7 XBRL TAXONOMY EXTENSION SCHEMA surf-20190630.xsd EX-101.SCH 43655
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE surf-20190630_cal.xml EX-101.CAL 51463
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE surf-20190630_def.xml EX-101.DEF 166422
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE surf-20190630_lab.xml EX-101.LAB 381299
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE surf-20190630_pre.xml EX-101.PRE 319132
Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Filer) CIK: 0001718108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38459 | Film No.: 191003720
SIC: 2836 Biological Products, (No Diagnostic Substances)